<DOC>
	<DOC>NCT01230008</DOC>
	<brief_summary>The use of Rituximab has been proposed to be useful and avoid the use of radiotherapy in diffuse large B-cell lymphoma with bulky disease.We assess efficacy of adjuvant radiotherapy in patients treated with R-CHOP</brief_summary>
	<brief_title>Radiotherapy in Primary Mediastinal Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<criteria>Diagnosis of primary mediastinal lymphoma No previous treatment performance status &lt; 2 HIV, Hepatis B and C negative Normal :Renal, hepatic, pulmonary and cardiac function pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>primary mediastinal lymphoma</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>rituximab</keyword>
</DOC>